Antiviral activity of selected cathelicidins against infectious bronchitis virus
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral activity of selected cathelicidins against infectious bronchitis virus
Authors
Keywords
-
Journal
Peptide Science
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-31
DOI
10.1002/pep2.24234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthetic Cationic Peptide IDR-1002 and Human Cathelicidin LL37 Modulate the Cell Innate Response but Differentially Impact PRRSV Replication in vitro
- (2019) Benoît Levast et al. Frontiers in Veterinary Science
- Innate antiviral immune response against infectious bronchitis virus and involvement of prostaglandin E2 in the uterine mucosa of laying hens
- (2018) M. Elhamouly et al. THERIOGENOLOGY
- Cathelicidins InhibitEscherichia coli–Induced TLR2 and TLR4 Activation in a Viability-Dependent Manner
- (2017) Maarten Coorens et al. JOURNAL OF IMMUNOLOGY
- Cathelicidins display conserved direct antiviral activity towards rhinovirus
- (2017) Filipa Henderson Sousa et al. PEPTIDES
- A reverse genetics system for avian coronavirus infectious bronchitis virus based on targeted RNA recombination
- (2017) Steven J. van Beurden et al. Virology Journal
- Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans
- (2016) Silke M. Currie et al. JOURNAL OF IMMUNOLOGY
- Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides
- (2016) Albert van Dijk et al. PLoS One
- Fungicidal Mechanisms of Cathelicidins LL-37 and CATH-2 Revealed by Live-Cell Imaging
- (2014) Soledad R. Ordonez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
- (2013) Emily Gwyer Findlay et al. BIODRUGS
- Avian host defense peptides
- (2013) Tryntsje Cuperus et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
- (2013) Silke M. Currie et al. PLoS One
- The long view: 40 years of infectious bronchitis research
- (2012) Jane K. A. Cook et al. AVIAN PATHOLOGY
- Molecular evolution and emergence of avian gammacoronaviruses
- (2012) Mark W. Jackwood et al. INFECTION GENETICS AND EVOLUTION
- Protegrin-1 Inhibits Dengue NS2B-NS3 Serine Protease and Viral Replication in MK2 Cells
- (2012) Hussin A. Rothan et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins
- (2012) S. Tripathi et al. JOURNAL OF GENERAL VIROLOGY
- Infectious bronchitis virus variants: a review of the history, current situation and control measures
- (2011) J. J. (Sjaak) de Wit et al. AVIAN PATHOLOGY
- Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
- (2011) Peter G. Barlow et al. PLoS One
- Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities
- (2009) Albert van Dijk et al. MOLECULAR IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started